SpermQT Prospective Observational Trial

Description

The goal of the study is to validate the ability of the Epigenetic Sperm Quality Test (SpermQT) to assess a man's sperm quality and corresponding success of infertility treatments.

Conditions

Male Infertility

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of the study is to validate the ability of the Epigenetic Sperm Quality Test (SpermQT) to assess a man's sperm quality and corresponding success of infertility treatments.

SpermQT Prospective Observational Trial

SpermQT Prospective Observational Trial

Condition
Male Infertility
Intervention / Treatment

-

Contacts and Locations

San Diego

Male Fertility and Sexual Medicine Specialists, San Diego, California, United States, 92120

Greenwood Village

Shady Grove Fertility, Greenwood Village, Colorado, United States, 80111

Orange

Yale Medicine, Orange, Connecticut, United States, 06477

Waltham

Boston IVF, Waltham, Massachusetts, United States, 02451

Houston

Inception Fertility, LLC, Houston, Texas, United States, 77081

Seattle

University of Washington, Seattle, Washington, United States, 98105

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * The subjects have been recommended to pursue IUI, or they have recently completed an IUI (regardless of outcome)
  • * Male partner is under 45 years of age
  • * Female partner is under 38 years of age
  • * The total motile sperm count from the raw semen analysis must be greater than or equal to 10 million
  • * The female or male partner have a BMI equal to or greater than 40
  • * The male partner has undergone male testosterone replacement therapy in the last 6 months
  • * Either the female or male partner have a history of recurrent pregnancy loss, defined as 2 or more consecutive clinical/ultrasound pregnancy losses
  • * There are any known factors contributing to female factor infertility, such as but not limited to:
  • * Severe Endometriosis (stage 3 or higher, endometrioma on ovaries)
  • * Multiple uterine fibroids 5cm or larger
  • * Severe Asherman's Syndrome
  • * Severe Mullerian anomaly
  • * Lack of tubal patency in at least one fallopian tubes

Ages Eligible for Study

18 Years to 45 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Inherent Biosciences,

Kristin Brogaard, PhD, PRINCIPAL_INVESTIGATOR, Inherent Biosciences

Study Record Dates

2026-01-01